Details of the Drug Formulations

General Information of Drug (ID: DMYX7NI)

• Drug Name: Acetohydroxamic Acid Drug Info
• Synonyms: AHA; Acethydroxamsaeure; Acethydroxamsaure; Acetohydroxamate; HAE; Lithostat; Acethydroxamic acid; Acethydroxamsaeure [German]; Acetohydroximic acid; Acetyl hydroxyamino; Acetylhydroxamic acid; Acide acetohydroxamique; Acide acetohydroxamique [French]; Acido acetohidroxamico; Acido acetohidroxamico [Spanish]; Acidum acetohydroxamicum; Acidum acetohydroxamicum [Latin]; Cetohyroxamic acid; Methylhydroxamic acid; SJX HLdmMAH; AHA (TN); Acetic acid, oxime; Acetohydroxamic acid [USAN:INN]; Lithostat (TN); N-Acetyl hydroxyacetamide; N-Acetylhydroxylamine; N-Hydroxyacetamide; N-hydroxyacetimidic acid; N-hydroxyethanimidic acid; S14-0751; Acetohydroxamic acid (USP/INN); Acetamide, N-hydroxy-(9CI)

Indication

Disease Entry	ICD 11	Status	REF
Urinary tract infection	GC08	Approved	[1]

• Therapeutic Class: Antiinfective Agents
• Cross-matching ID:
  PubChem CID: 1990
  ChEBI ID: CHEBI:27777
  CAS Number: 546-88-3
  TTD ID: D0R9BG
  ACDINA ID: D00805

Full List of Drug Formulations Containing This Drug

Acetohydroxamic Acid 250mg tablet

Company	Formulation ID	FDA Description
Mission Pharmacal	F23063	Cellulose; Microcrystalline; Silicon Dioxide; Magnesium Stearate; Peppermint Oil

References

• [1] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018749.